According to Nirvana Life Sciences latest financial reports the cash on hand of NIRV is $9.25K, an decrease of -65.08% to 2022. At the end of 2022 company had $26.48K cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
Year | Cash on Hand | Change |
---|---|---|
2023 | $9.25K | -65.08% |
2022 | $26.48K | -92.48% |
2021 | $352.19K | 21017.89% |
2020 | $1.67K | 230.35% |
2019 | $504.83 | - |